Compare MMS & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMS | HIMS |
|---|---|---|
| Founded | 1975 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.6B |
| IPO Year | 1997 | 2019 |
| Metric | MMS | HIMS |
|---|---|---|
| Price | $78.06 | $15.61 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $26.38 |
| AVG Volume (30 Days) | 734.6K | ★ 28.8M |
| Earning Date | 05-07-2026 | 05-25-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 10.42 | N/A |
| EPS | ★ 1.70 | 0.51 |
| Revenue | ★ $2,392,236,000.00 | $2,347,637,000.00 |
| Revenue This Year | $0.44 | $19.27 |
| Revenue Next Year | $5.15 | $17.96 |
| P/E Ratio | $45.89 | ★ $30.67 |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $64.68 | $13.74 |
| 52 Week High | $100.00 | $70.43 |
| Indicator | MMS | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 46.65 | 31.27 |
| Support Level | $77.59 | $13.74 |
| Resistance Level | $89.28 | $59.94 |
| Average True Range (ATR) | 2.32 | 1.20 |
| MACD | 1.04 | 0.58 |
| Stochastic Oscillator | 82.88 | 59.75 |
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.